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http://journal.chemistrycentral.com/content/7/1/15RESEARCH ARTICLE Open AccessOzone oxidation of antidepressants in
wastewater –Treatment evaluation and
characterization of new by-products by
LC-QToFMS
André Lajeunesse1, Mireille Blais2, Benoît Barbeau2, Sébastien Sauvé3 and Christian Gagnon1*Abstract
Background: The fate of 14 antidepressants along with their respective N-desmethyl metabolites and the
anticonvulsive drug carbamazepine was examined in a primary sewage treatment plant (STP) and following
advanced treatments with ozone (O3). The concentrations of each pharmaceutical compound were determined in
raw sewage, effluent and sewage sludge samples by LC-MS/MS analysis. The occurrence of antidepressant
by-products formed in treated effluent after ozonation was also investigated.
Results: Current primary treatments using physical and chemical processes removed little of the compounds (mean
removal efficiency: 19%). Experimental sorption coefficients (Kd) of each studied compounds were also calculated.
Sorption of venlafaxine, desmethylvenlafaxine, and carbamazepine on sludge was assumed to be negligible (log Kd ≤ 2),
but higher sorption behavior can be expected for sertraline (log Kd ≥ 4). Ozonation treatment with O3 (5 mg/L) led to a
satisfactory mean removal efficiency of 88% of the compounds. Screening of the final ozone-treated effluent samples by
high resolution-mass spectrometry (LC-QqToFMS) did confirm the presence of related N-oxide by-products.
Conclusion: Effluent ozonation led to higher mean removal efficiencies than current primary treatment, and therefore
represented a promising strategy for the elimination of antidepressants in urban wastewaters. However, the use of O3
produced by-products with unknown toxicity.
Keywords: Antidepressants, Ozone, LC-MS/MS, Sewage treatment plants, Biosolids, Side-productsBackground
Urban wastewaters are one of the major sources of
pharmaceutically-active compounds (PhACs) into aquatic
environments [1,2]. The elimination of many pharmaceu-
ticals in sewage treatment plants (STPs) being often
incomplete [3-5], effluents from STPs thus contribute to a
significant load of pharmaceutical residues in the receiving
waters [6]. Little is however known on the potential
release of transformation by-products following advanced
wastewater treatments.
Among the most prescribed PhACs throughout the
world are the psychiatric drugs that include the* Correspondence: christian.gagnon@ec.gc.ca
1Environment Canada, Wastewater and Effluents Section, Water Science and
Technology Directorate, 105 McGill Street, Montreal, Quebec H2Y 2E7,
Canada
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© 2013 Lajeunesse et al.; licensee Chemistry C
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumantidepressants and the antiepileptic drug carbamaze-
pine (CAR) frequently used for treating schizophrenia
and bipolar disorder [7,8]. The persistent drug CAR
largely sold in Canada is currently prescribed in combi-
nation to antidepressants all over the world during therapy.
Therefore, a monitoring of CAR is also required to better
assess its environmental fate in different matrices. Toxicity
studies of these neuroactive compounds provided evidence
for biological effects on aquatic organisms [9-13]. Although
the occurrence of antidepressants in sewage effluents
[6,14-17] and wastewater sludge [18-20] has been demon-
strated, the fate of these substances following different
treatments in STPs has not been extensively documented.
A previous study indicated that a primary treatment
process has limited capability to remove and/or degrade
antidepressants residues in wastewater [15]. Further resultsentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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(e.g. secondary treatment with activated sludge) revealed
moderate potential (mean removal efficiency ≤ 30%) to
degrade antidepressants from wastewater [20]. Therefore,
alternative treatment technologies may have to be imple-
mented or combined to achieve high removal of com-
pounds in STPs [21]. As such, experimental evidence
reported elsewhere clearly demonstrates that existing
limitations in primary and secondary processes can be
overcome with more advanced treatment strategies inclu-
ding chemical oxidation with ozone or the use of high
pressure membrane technologies [22-24].
While conventional activated sludge treatments were
shown to degrade pharmaceuticals to varying extent [25],
ozone (O3) treatments showed promising results in terms
of removal efficiencies as an efficient oxidizer to remove
endocrine disruptors compounds and pharmaceuticals
products in wastewater [26,27]. Generally, O3 reacts with
organic molecules through either the direct reaction with
molecular O3 (via 1–3 dipolar cyclo addition reaction on
unsaturated bonds, and electrophilic reaction on aromatics
having electron donor groups e.g. OH, NH2) or by decom-
position through the formation of chain intermediate free
radicals, including the hydroxyl radical OH• (less selective
reaction on saturated aliphatic molecules) [26,28]. The
stability of dissolved ozone is readily affected by pH, ultra-
violet (UV) light, ozone concentration, and the concentra-
tion of radical scavengers such carbonate – bicarbonate
species, the dissolved organic carbon and humic acids
[28,29]. Except for few experiments completed with fluoxe-
tine (FLU), the number of studies dedicated to the elimi-
nation of antidepressants by oxidation processes (e.g. TiO2
membrane reactor, O3 with UV activation, O3 with H2O2)
has been rather limited [22-24]. Since molecular O3 is a
selective electrophile that reacts quickly with amine and
double bounds moieties [26], ozonation should be efficient
to degrade antidepressants mostly constituted of secondary
or tertiary amine and conjugated rings. However, as
reported for β-Lactam antibacterial agents (e.g. penicillin G,
cephalexin) spiked in wastewater, O3 reaction leads to the
formation of biologically active sulfoxides analogues [30].
For antidepressants, no study on the transformation
products following an O3 treatment in wastewater is
currently available. As yet, no data is reported neither on
by-products toxicity. Nevertheless, formation of N-oxide,
amide, aldehyde, and carboxylic acid by-products is
expected after ozonation of secondary and tertiary amine
compounds in aqueous solutions [31,32].
In the present work, the effectiveness of ozone treatments
in terms of removal efficiency is tested at three different
concentrations for the oxidation of 14 antidepressants
along with their direct N-desmethyl metabolites and the
anticonvulsive drug carbamazepine during ozonation of a
primary-treated effluent. The goal of the study was also toinvestigate the occurrence of antidepressant by-products
formed in treated effluent after ozonation.
Experimental
Chemicals and materials
All certified standards were > 98% purity grade. Fluoxetine
(FLU), norfluoxetine (NFLU), paroxetine (PAR), sertraline
(SER), (S)-citalopram (CIT), fluvoxamine (FLUVO), des-
methylfluvoxamine (DFLUVO), mirtazapine (MIR), and
desmethylmirtazepine (DMIR) were provided by Toronto
Research Chemicals Inc. (North York, Ontario, Canada).
Desmethylsertraline (DSER), venlafaxine (VEN), O-desme-
thylvenlafaxine (DVEN), and the surrogate standard
bupropion-d9 were obtained from Nanjing Jinglong
PharmaTech (Nanjing, China). Amitriptyline (AMI), nor-
triptyline (NTRI), carbamazepine (CAR), and surrogate
standard 10,11-dihydrocarbamazepine were purchased
from Sigma-Aldrich Co. (St. Louis, Missouri, USA),
while internal standard cis-tramadol13C-d3 was purchased
from Cerilliant Corp. (Round Rock, Texas, USA). The
high-performance liquid chromatography–grade solvents
(methanol and acetonitrile) and ammonium hydroxide
were provided by Caledon Laboratories Ltd. (Georgetown,
Ontario, Canada). Reagent-grade hydrochloric acid, acetic
acid, ammonium bicarbonate, and ACS grade ethyl acetate
were provided by American Chemicals Ltd. (Montreal,
Quebec, Canada). Solid-phase extraction (SPE) cartridges
of 6 mL, 200 mg Strata™ X-C were purchased from Phe-
nomenex (Torrance, California, USA). Stock solutions of
100 mg/L of each substance were prepared in methanol
and stored at 4°C in amber glass bottles that were previ-
ously washed with methanol. The chemical structures of
the selected compounds are provided in Figure 1.
Instrumentation
Liquid chromatography (LC)
Liquid chromatography (LC) was performed using an
Agilent 1200 Series LC system equipped with binary
pumps, degasser, and a thermostated autosampler main-
tained at 4°C. The antidepressants were separated on a
KinetexW XB-C18 column (100 mm × 2.10 mm, 1.7 μm)
using a binary gradient made of (A) ammonium bicarbo-
nate (5 mM) pH 7.8, and (B) acetonitrile at a flow rate of
400 μL/min. The volume of injection was 15 μL for
influent, effluent, and sludge extracts. The gradient used
was (%B): 0 min (10%), 6 min (80%), 10 min (80%), 12 min
(90%), 14 min (10%), and 16 min (10%). An equilibration
time of 4 min was used resulting in a total run time of
20 min. The column temperature was maintained at 40°C.
Tandem-mass spectrometry (QqQMS, QqToFMS)
For quantitative analysis, the LC system was coupled to a
6410 triple quadrupole mass spectrometer (QqQMS)
manufactured by Agilent Technologies (Santa Clara, CA,
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Figure 1 Chemical structures of the studied compounds.
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http://journal.chemistrycentral.com/content/7/1/15USA) equipped with an electrospray ionization (ESI)
source. The capillary was maintained at 4000 V, and the
cone voltage was optimized for each compound in the
positive-ion mode (ESI+). Additional detector parameters
were held constant for all antidepressants: gas temperature
325°C; gas flow 10 L/min; nebulizer 35 psi and dwell time
50 ms. For qualitative by-products analysis, a 6530 quad-
rupole time-of-flight mass spectrometer (QqToFMS) also
manufactured by Agilent Technologies, was utilized. The
QqToFMS was equipped with a thermal gradient focusing
ESI source (Jet Stream technology). Source parameters
consisted of the following: gas temperature 325°C; sheath
gas temperature 350°C; sheath gas flow 11 L/min; drying
gas flow 5 L/min; nebulizer 35 psig, fragmentor 100 V and
capillary voltage 4000 V. The QqToFMS was operated in
the 4 GHz High Resolution mode with a low mass range
(1700m/z). Purine (121.050873m/z) and Hexakis
(922.009798m/z) were used as internal reference masses
to improve mass accuracy. Initial tests were performed on
treated effluent extracts in high resolution tandem MS
mode using a mass range of m/z 100–400 (specific
collision energy: 0 V) at a rate of 5 spectra/s to screen the
exact [M+H]+ masses of the precursor ions. Identified
compounds were then fragmented with different specificcollision energies varying between 0 and 10 V. For both
detection systems, the MassHunter software from Agilent
Technologies was used for data acquisition and proces-
sing. Optimized parameters for QqQMS are listed in a
table (Additional file 1).
Sample location and collection
Sample location
All samples were collected onsite at the sewage treatment
plant (STP) of the city of Repentigny (30 km North-East of
Montreal, Qc, Canada) in amber glass bottles previously
washed with methanol during an ozonation pilot-study
performed in June 2011. The Repentigny STP typically
treats 25 000 m3 of raw sewage daily for a population of
approximately 60 000 persons. Wastewater is primary-
treated using both physical and chemical treatments
(e.g. flocculation of suspended matters with alum and/or
FeCl3). For the purpose of this study, treated wastewater
was further experimentally ozone-oxidized on site. Main
characteristics of the Repentigny STP are reported in
Table 1. Ozonation of the effluent consisted of an ozone
(O3) generator (Ozone Solution, Model: TG10–Ozone
Solution) fed with ultra-pure oxygen (99.9999%). Gaseous
ozone was bubbled in a ceramic diffuser located inside a
Table 1 Main water characteristics of the Repentigny sewage treatment plant
Wastewater Temperature (°C) pH Alkalinity (mg/L) CaCO3 TSS (mg/L) BOD5 (mg/L) COD (mg/L)
Raw sewage (Influent) 17 7.3 189 146 136 227
Effluent – 7.2 165 12 36 59
TSS: Total Suspended Solids, BOD5: Biochemical Oxygen Demand, COD: Chemical Oxygen Demand.
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http://journal.chemistrycentral.com/content/7/1/15vertical column (6.3 m, 5.08 internal diameter) where both
gas transfer and contact time occurred simultaneously. The
water flow was maintained at 1.2 L/min, while the O3 flow
rate injection was kept around 75 to 110 N mL/min
(head pressure: 10 psi). Contact time of O3 with treated
effluent was 10 min. Ozone transfer was monitored by
measuring off-gas ozone concentrations using the standard
KI procedure [33]. Applied ozone dosages were then
corrected for ozone transfer efficiency which varied from
75 to 80%. Total and residual dissolved O3 concentrations
were determined following the standard indigo trisulfonate
colorimetric method [34].Sample collection
Typically, water samples of influent (raw sewage), primary-
treated effluent, and ozone treated effluent were collected
between 10:00 and 14:00 in polyethylene containers and
stored on ice. Samples of wet primary sewage sludge
(biosolids) were also collected on the same days and imme-
diately stored on ice in polyethylene bottles. In the labora-
tory, approximately 10 g of wet biosolid material was
filtered with a 0.7 μm glass fiber filter to get a dewatered
sludge sample that was frozen, freeze-dried, and stored
at −80°C until use. All samples were extracted and analyzed
within 48 h after their collection.Table 2 Mean concentrations of studied compounds extracte
samples from the Repentigny STP
Compounds Wastewaters (n = 2)
Raw sewage (ng/L) Effluent (ng/L) R
CIT 207 ± 12 148 ± 16
SER 13 ± 1 9.4 ± 0.1
DSER 23 ± 1 19 ± 3
AMI 223 ± 21 195 ± 11
NTRI 21 ± 3 19 ± 4
VEN 4061 ± 153 3144 ± 107
DVEN 4185 ± 133 3448 ± 279
CAR 747 ± 14 714 ± 13
FLU 11 ± 1 9.5 ± 0.6
NFLU 7.0 ± 0.4 6.5 ± 0.2
PAR 15 ± 1 13 ± 4
MIR 171 ± 20 109 ± 3
DMIR 41 ± 1 25 ± 1Sample extraction
Sewage samples
Extraction method for raw sewage and effluent samples to
be analyzed for various classes of antidepressants was done
as previously described [15]. The decision to incorporate
the neutral drug carbamazepine (CAR) amongst the basic
antidepressants forced us to modify the protocol by
replacing the strong cation exchange cartridge by a mixed-
mode cartridge for sample purification (Strata X-C,
Phenomenex) [20].
The validated extraction protocol used here was simi-
lar to that described in Lajeunesse et al. [20]. Each
250 mL of filtered sewage sample were spiked with
100 μL of a surrogate standard solution prepared in
methanol (bupropion-d9 / 10,11-dihydrocarbamazepine,
2.5 mg/L) and addition of 2.5 mL of methanol before
lowering the pH to around 3 with 100 μL of phosphoric
acid (85%). The mixed-mode solid phase extraction
(SPE) cartridges were conditioned with 4 mL of metha-
nol followed by at least 8 mL of Milli-Q water. SPE was
performed with a VAC ELUT SPS24 manifold (Varian)
at flow rates ~10–15 mL/min. After extraction, all
cartridges were washed with 2 mL of HCl (0.1 M). The
CAR molecules were eluted first with 2 × 2 mL of ethyl
acetate prior the evaporation of the solvent in the
tubes to dryness under a gentle stream of nitrogen.d in wastewater (raw sewage, effluent) and biosolid
Biosolids (n = 2)
emoval Eff. (%) Sludge (ng/g) Kd (L/kg) log Kd
29 172 ± 38 1.2 × 103 3.1
28 43 ± 5 4.6 × 103 3.7
17 31 ± 6 1.6 × 103 3.2
13 58 ± 22 2.9 × 102 2.5
6.8 9.0 ± 1.1 4.7 × 102 2.7
23 227 ± 49 7.2 × 101 1.9
18 73 ± 2 2.1 × 101 1.3
4.4 26 ± 12 3.6 × 101 1.6
16 15 ± 1 1.6 × 103 3.2
7.1 3.8 ± 0.6 5.8 × 102 2.8
9.0 5.6 ± 3.6 4.2 × 102 2.6
36 27 ± 6 2.5 × 102 2.4
38 13 ± 1 5.4 × 102 2.7
Venlafaxine (VEN)
Paroxetine (PAR)
Citalopram (CIT)
Fluoxetine (FLU)
Figure 2 Representative LC-QqQMS chromatograms of selected antidepressants detected in primary-treated effluent sample extract.
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http://journal.chemistrycentral.com/content/7/1/15Meanwhile, all SPE cartridges were washed with 2 mL of
methanol. The antidepressants retained onto the sorbent
were then eluted with 2 × 2 mL of a solution of 5% (v/v)
NH4OH in methanol. The combined fractions (e.g. CAR
and antidepressants) were mixed with 100 μL of a solu-
tion of cis-tramadol13-d3 in methanol (5 mg/L) as the
internal standard and the solvent in tubes was evapo-
rated to dryness with nitrogen. The dried extracts were
reconstituted with 0.50 mL of the mobile phase solution0,0
0,2
0,4
0,6
0,8
1,0
re
la
ti
v
e
 K
d
 
Figure 3 Relative Kd values of the studied compounds.of ammonium bicarbonate (5 mM) pH 7.8 – acetonitrile
(1:1 v/v) in injection vials and later injected in
LC-QqQMS or LC-QqToFMS for analysis.
Sewage sludge samples
The simultaneous extraction of CAR and antidepressants
in biosolid samples was completed using the validated
protocol reported in Lajeunesse et al. [20]. Briefly, 0.200 g
of freeze-dried sludge is transferred to a 16 × 150 mm
Table 3 Mean concentrations and removal of antidepressants contained in final effluent following ozonation
Compounds Conc. (n=2) Ozone 5 mg/L Conc. (n=2) Ozone 9 mg/L
Effluent (ng/L) Disinfected effluent (ng/L) Removal Eff. (%) Effluent (ng/L) Disinfected effluent (ng/L) Removal Eff. (%)
CIT 186 ± 27 123 ± 11 34 148 ± 16 56 ± 1 62
SER 14 ± 2 – 100 9.4 ± 0.1 – 100
DSER 23 ± 1 – 100 19 ± 3 – 100
AMI 106 ± 5 36 ± 1 66 195 ± 11 15 ± 1 92
NTRI 18 ± 1 0.18 ± 0.01 99 19 ± 4 – 100
VEN 2194 ± 191 963 ± 43 56 3144 ± 107 986 ± 27 69
DVEN 2319 ± 11 – 100 3448 ± 279 – 100
CAR 716 ± 4 12 ± 1 98 714 ± 13 – 100
FLU 6.3 ± 0.8 – 100 9.5 ± 0.6 – 100
NFLU 11 ± 2 – 100 6.5 ± 0.2 – 100
PAR 9.0 ± 1.3 – 100 13 ± 4 – 100
MIR 104 ± 1 1.6 ± 0.1 98 109 ± 3 – 100
DMIR 41 ± 4.1 3.3 ± 0.4 92 25 ± 1 – 100
Note: Measured residual O3 concentrations for 5, 9 and 13 mg/L of O3 were respectively 0.000, 0.036 and 0.514 mg/L.
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http://journal.chemistrycentral.com/content/7/1/15borosilicate glass screw-top conical tube before adding
8 mL of a solution composed of methanol / 0.1 M acetic
acid buffer solution pH 4.0 (1:1 v/v). Each tube were
spiked with 100 μL of a surrogate standard solution
prepared in methanol (bupropion-d9 / 10,11-dihydrocar-
bamazepine, 2.5 mg/L). Samples were then shaken vigo-
rously and mixed on a rotary extractor (Caframo REAX)
for 15 min. After extraction, tubes were placed in a soni-
cation bath for 15 min before adding 4 mL of Milli-Q
water to each tube. Tubes were then centrifuged (320 x g)
at room temperature for 5 min. Following the SPE proto-
col described previously for aqueous sewage samples,
supernatants were transferred directly on mixed-mode
cartridges. The final extracts were reconstituted in 0.5 mL
of the mobile phase solution of ammonium bicarbonate
(5 mM) pH 7.8 – acetonitrile (1:1 v/v), filtered with a0
20
40
60
80
100
R
em
o
va
l  
(%
)
  Primary
  Primary + Ozone (9 mg/L
Figure 4 Reduction of antidepressants and CAR in primary-treated efPTFE 0.45 μm filter, and then injected in LC-QqQMS
system for analysis.
Results and discussion
Antidepressants in raw sewage and primary-treated
effluent
Out of the 15 compounds investigated, 13 were detected in
raw sewage samples and only the antidepressant FLUVO
and its direct metabolite DFLUVO were not detected.
Compound concentrations ranged from 6.5 ng/L (NFLU)
to 4185 ng/L (DVEN) (Table 2). A typical chromatogram of
the detected antidepressants VEN, CIT, PAR, and FLU in a
primary-treated effluent extract is depicted in Figure 2.
Overall, moderate to poor removal efficiencies were ob-
tained for most antidepressants (mean removal efficiency
of 19%). Results showed that current enhanced primary  Primary + Ozone (5 mg/L)
)
fluent by ozone disinfection at 5 and 9 mg/L O3 concentration.
Figure 5 LC-QqToFMS chromatograms of N-oxide by-products detected in disinfected effluent (O3 concentration: 5 mg/L).
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http://journal.chemistrycentral.com/content/7/1/15treatment using physical and chemical processes removed
little of the studied compounds (Table 2). The substances
with lowest removal efficiencies were CAR (4.4%), along
with the antidepressant metabolites NTRI (6.8%) and
NFLU (7.1%). Similar low removal rates were previously
reported for antidepressants [15] and CAR [35] in primary-
treated effluents. Despite a noteworthy reduction of to-
tal suspended solids – TSS (Table 1), the weak removal(a)   0 V collision energy
(b)   10 V collision energy
Figure 6 LC-QqToFMS mass spectra of N-oxide VEN in disinfected effl
energy (a) and 10 V collision energy (b).obtained for this primary treatment strongly suggests that a
mechanism other than chemical adsorption would be
required to effectively remove antidepressants from urban
wastewater.
Antidepressants in sewage sludge
Primary sludge samples consistently displayed quantifiable
amounts of the studied compounds (excepted FLUVO anduent (O3 concentration: 5 mg/L): product ions at 0 V collision
Lajeunesse et al. Chemistry Central Journal 2013, 7:15 Page 8 of 11
http://journal.chemistrycentral.com/content/7/1/15DFLUVO) (Table 2). Highest mean concentrations in
biosolid samples were found for VEN (227 ng/g), CIT
(172 ng/g), DVEN (70 ng/g), AMI (58 ng/g), and SER
(43 ng/g). Our results are consistent with the mean concen-
trations for the antidepressants FLU (123 ng/g) and PAR
(41 ng/g) reported by Radjenović et al. [18] in primary
sludge samples. Interestingly, among reported concentra-
tions, less antidepressant metabolites were detected in
sewage sludge samples for N-desmethyl metabolites in
comparison to their respective parent molecules. These
findings suggest that more polar compounds have a lower
affinity for the solid phase of sewage sludge and hence have
limited removal efficiencies.
In order to describe the fate and behavior of antidepres-
sants in primary STP, specific partitioning coefficient (Kd)
values for antidepressants and metabolites to sewage sludge
were estimated. The Kd coefficients were calculated using
the ratio [Sludge] / [Effluent]; where [Sludge] is the concen-
tration of antidepressants in sewage sludge (ng/kg) and
[Effluent] is the concentrations of antidepressants in final
effluent (ng/L) [36]. The obtained Kd values were applied to
evaluate the affinity of compounds to primary STP sludge.
The Kd values were lowest for VEN, DVEN, and CAR
(Table 2) with values ranging from 21 to 72 L/kg. With log
Kd values ≤ 2, sorption to solid matter for VEN, DVEN,
and CAR is therefore defined as negligible [36]. Higher(a)   0 V collision energy
(b)   10 V collision energy
Figure 7 LC-QqToFMS mass spectra of N-oxide DVEN in disinfected e
energy (a) and 10 V collision energy (b).sorption behaviour is expected for SER, DSER, FLU, and
CIT which have higher relative Kd values (Figure 3).
Antidepressants in treated effluent - ozonation
Ozonation of the primary-treated effluent did degrade
antidepressants with higher efficiency, yielding a mean
removal efficiency of 88% when 5 mg/L of ozone was
applied (Table 3). Ten (10) of the 13 compounds initially
present in the effluent had removal efficiencies ≥ 92%
(Figure 4). Only three substances (CIT, AMI, and VEN)
yielded lower removal efficiencies, being 34, 66, and 56%
respectively. As discussed in background section, the
ozonation mechanism is directly affected by the ozone
stability. Thus, scavengers compounds (e.g. carbonate,
bicarbonate, dissolved organic and humic acids) present in
effluent may have slowed down the ozone decomposition
by inhibiting the free-radical reaction chain, and conse-
quently the formation of hydroxyl radicals OH• necessary
to degrade saturated aliphatic carbon chain on molecules
[28]. Since, CIT, AMI and VEN have long tertiary amine
aliphatic chains on their chemical structures, steric hin-
drance may have prevented ozone reactions normally
expected at specific sites of the molecules [37]. In present
study, it is very difficult to assess the relative importance of
direct ozone-mediated transformations, and thereby to
draw a general conclusion about each compound andffluent (O3 concentration: 5 mg/L): product ions at 0 V collision
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http://journal.chemistrycentral.com/content/7/1/15transformation during ozonation in a single matrix with
varying OH• scavenging capacities, under a certain pH con-
dition. Obviously, the work presented therein was not
intended to the understanding of ozonation mechanisms.
However, as reported by Zwiener and Frimmel [38], so-
called radical scavengers compete with pharmaceuticals for
the OH-radicals and by this decrease the degradation kine-
tics of the targeted pharmaceuticals. Nevertheless, removal
efficiency increased to 94% for most compounds using an
optimal ozone dose of 9 mg/L (Figure 4). At the highest
ozone treatment tested (i.e. 13 mg/L), all antidepressants
were oxidized and degraded from primary-treated effluent
samples. Current limitation of the analytical method may
have lead to undetected polar compounds that would
require different chromatographic and instrumental adjust-
ments. However, Snyder et al. [26] have reported very simi-
lar removal efficiencies for CAR (> 99%) and FLU (> 93%)
for comparable effluent samples treated with 3.6 mg/L of
O3. Under controlled conditions using a 5–L glass jacketed
reactor, Rosal et al. [39] observed high removal efficiencies
for CAR (98%), CIT (93%), FLU (100%), and VEN (88%) in
wastewater samples exposed to 2.4 – 6.1 mg/L of O3 for
less than 5 min.
Characterization of new by-products by LC-QqToFMS
In this study, the two most abundant antidepressants
detected in raw sewage were VEN and its N-desmethyl
metabolite DVEN. Therefore, primary-treated effluent sam-
ples previously treated with O3 at different concentrations
were screened by LC-QqToFMS to confirm the presence of
related by-products of these two compounds.
Initial tests performed on treated effluent extracts
(O3 dose: 5 mg/L) in high resolution tandem MS mode
using a mass range of m/z 100–400 (specific collision
energy: 0 V) enabled the positive detection of N-oxide by-
product precursor ions for VEN (m/z 294.2059, accurate
mass error: -3.40 ppm) and DVEN (m/z 280.1903, accu-
rate mass error: -3.21 ppm). The chromatograms and
mass spectrums of both characterized by-products are
depicted respectively in Figures 5, 6a, and 7a. Precursor
[M + H]+ ions were isolated in the first quadrupole of the
QqToF and then fragmented in the collision cell at 10 V
in order to perform accurate mass measurements on the
resulting fragment ions. Isolation and fragmentation of the
precursor ion of N-oxide VEN (m/z 294.2057, accurate
mass error: -4.08 ppm) generated a product ion at m/z
127.1125 (Figure 6b). This ion fragment corresponds to
[C8H14O + H]
+ and has an accurate mass error from
theoretical values of 1.57 ppm. As for the N-oxide DVEN
when its precursor ion at m/z 280.1910 (accurate mass
error: –0.71 ppm) was isolated and fragmented, an ion at
m/z 113.0966 was observed that could be interpreted as
[C7H12O + H]
+ with an accurate mass error of ± 0.00 ppm
(Figure 7b). During MS/MS characterization, it wasdecided to keep a large isolation width of the quadrupole
(e.g. 4 m/z) to increase sensitivity. Hence, MS/MS mass
spectra of N-oxide VEN and DVEN likely contained prod-
uct ions of other molecules that may have interfered with
the mass spectra interpretation. According to European
Commission Decision 2002/657/EC [40], at least 4 “iden-
tification” points are required in order to confirm the
presence of a substance. Since one high-resolution precur-
sor ion and one high-resolution product ion were ob-
tained during experiments (total identification points: 2 +
2.5 = 4.5), the results of our study (with accurate mass
errors < ± 5.00 ppm) were considered sufficient to con-
firm the presence of the N-oxide by-products.
Additional LC-QqToFMS analysis performed on effluent
extracts previously treated with 9 mg/L of O3 confirmed
also the presence of both N-oxide by-products. When the
concentration of O3 reached 13 mg/L, none of the by-
products were detected in corresponding effluent samples.
This suggests that an optimal O3 dosage would be required
to completely degrade the N-oxide by-products from trea-
ted effluents. Additional tests performed on raw sewage
(influent) and primary-treated effluent confirmed the ab-
sence of the two N-oxide by-products prior ozone treat-
ments. To our knowledge, the present study is the first one
to report the characterization of antidepressant by-products
in municipal effluent samples after experimental ozone
treatment.
Conclusions
This study described the fate and behavior of antidepres-
sants and their N-desmethyl metabolites in a primary STP
following ozone treatment. Effluent ozonation led to
higher mean removal efficiencies than current primary
treatment, and therefore has represented a promising
strategy for the elimination of antidepressants in urban
wastewaters. However, the use of O3 has produced
N-oxide by-products with unknown toxicity. Of particular
concern is the potential that removal of pharmaceuticals
following wastewater disinfection using advanced oxida-
tion process (i.e. ozonation) could generate by-products of
similar parent chemical structures that would need to be
identified, quantified and evaluated for their toxicity.
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